Pan Xiaoqi, Ma Xiao, Jiang Yinxiao, Wen Jianxia, Yang Lian, Chen Dayi, Cao Xiaoyu, Peng Cheng
School of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu 611137, China.
School of Public Health, Chengdu University of Traditional Chinese Medicine, Chengdu 611137, China.
Evid Based Complement Alternat Med. 2020 Oct 5;2020:7171498. doi: 10.1155/2020/7171498. eCollection 2020.
Liver fibrosis resulting from continuous long-term hepatic damage represents a heavy burden worldwide. Liver fibrosis is recognized as a complicated pathogenic mechanism with extracellular matrix (ECM) accumulation and hepatic stellate cell (HSC) activation. A series of drugs demonstrate significant antifibrotic activity in vitro and in vivo. No specific agents with ideally clinical efficacy for liver fibrosis treatment have been developed. In this review, we summarized the antifibrotic effects and molecular mechanisms of 29 kinds of common natural products. The mechanism of these compounds is correlated with anti-inflammatory, antiapoptotic, and antifibrotic activities. Moreover, parenchymal hepatic cell survival, HSC deactivation, and ECM degradation by interfering with multiple targets and signaling pathways are also involved in the antifibrotic effects of these compounds. However, there remain two bottlenecks for clinical breakthroughs. The low bioavailability of natural products should be improved, and the combined application of two or more compounds should be investigated for more prominent pharmacological effects. In summary, exploration on natural products against liver fibrosis is becoming increasingly extensive. Therefore, natural products are potential resources for the development of agents to treat liver fibrosis.
持续长期肝损伤导致的肝纤维化在全球范围内都是一个沉重负担。肝纤维化被认为是一种复杂的致病机制,涉及细胞外基质(ECM)积聚和肝星状细胞(HSC)激活。一系列药物在体外和体内均显示出显著的抗纤维化活性。目前尚未开发出具有理想临床疗效的肝纤维化治疗特异性药物。在本综述中,我们总结了29种常见天然产物的抗纤维化作用及分子机制。这些化合物的作用机制与抗炎、抗凋亡和抗纤维化活性相关。此外,通过干扰多个靶点和信号通路来实现实质肝细胞存活、HSC失活以及ECM降解,也参与了这些化合物的抗纤维化作用。然而,临床突破仍存在两个瓶颈。天然产物的低生物利用度有待提高,并且应研究两种或更多种化合物的联合应用以获得更显著的药理作用。总之,针对肝纤维化的天然产物探索正变得越来越广泛。因此,天然产物是开发肝纤维化治疗药物的潜在资源。